Podcast #33: Foreign-Sponsored Clinical Trials Under China's Human Genetic Resources Regime – Tina Wu, Haiwen & Partners

May 14, 2021 | BY

Vincent Chow

China's HGR regime still delays foreign-sponsored clinical research despite recent streamlining of review process

Share:

Human genetic resources such as organs, cells, and tissue are crucial to the clinical trials that pharmaceutical multinationals conduct in order to get their products registered for use in China,